Skip to main content
PMC home page
BMC Public Health logoLink to BMC Public Health
. 2008 Sep 11;8:309. doi: 10.1186/1471-2458-8-309

Association between fertility and HIV status: what implications for HIV estimates?

Eugene J Kongnyuy 1,✉, Charles S Wiysonge 2
PMCID: PMC2546405  PMID: 18786250

Abstract

Background

Most estimates of HIV prevalence have been based on sentinel surveillance of pregnant women which may either under-estimate or over-estimate the actual prevalence in adult female population. One situation which can lead to either an underestimate or an overestimate of the actual HIV prevalence is where there is a significant difference in fertility rates between HIV-positive and HIV-negative women. Our aim was to compare the fertility rates of HIV-infected and HIV-uninfected women in Cameroon in order to make recommendations on the appropriate adjustments when using antenatal sentinel data to estimate HIV prevalence

Methods

Cross-sectional, population-based study using data from 4493 sexually active women aged15 to 49 years who participated in the 2004 Cameroon Demographic and Health Survey.

Results

In the rural area, the age-specific fertility rates in both HIV positive and HIV negative women increased from 15–19 years age bracket to a maximum at 20–24 years and then decreased monotonically till 35–49 years. Similar trends were observed in the urban area. The overall fertility rate for HIV positive women was 118.7 births per 1000 woman-years (95% Confidence Interval [CI] 98.4 to 142.0) compared to 171.3 births per 1000 woman-years (95% CI 164.5 to 178.2) for HIV negative women. The ratio of the fertility rate in HIV positive women to the fertility rate of HIV negative women (called the relative inclusion ratio) was 0.69 (95% CI 0.62 to 0.75).

Conclusion

Fertility rates are lower in HIV-positive than HIV-negative women in Cameroon. The findings of this study support the use of summary RIR for the adjustment of HIV prevalence (among adult female population) obtained from sentinel surveillance in antenatal clinics.

Background

The prevalence of Human Immunodeficiency Virus (HIV) is a measure of disease burden which is important in evaluating HIV prevention programmes and in designing new preventive strategies. Most estimates of HIV prevalence in developing countries have been based on sentinel surveillance of pregnant women [1]. HIV prevalence among pregnant women in antenatal clinics (ANC) closely approximates HIV prevalence in the adult population. ANC data is sometimes used to estimates HIV prevalence in general female population, instead of the general adult population (both males and females). This assumption is, however, unfounded [2]. Women who adopt abstinence or correct and consistent condom use in response to HIV prevention programmes are less likely to be pregnant and equally less likely to contract HIV infection. As such, sentinel surveillance of pregnant women would over-estimate HIV prevalence in the general female population. On the other hand, there is some evidence that HIV-1 could impair fertility [3,4]. If HIV infected women are less likely to be pregnant because of impairment of their fertility by the HIV virus, the use of sentinel surveillance would under-estimate the HIV prevalence.

Research comparing ANC estimates of HIV prevalence with HIV prevalence from population-based studies has shown that ANC figures closely estimate the actual population prevalence [5-7]. However, the findings have not been consistent [8]. Saphonn et al (2002) reported that although the prevalence of HIV in ANC was good for monitoring trends, it over-estimated HIV prevalence in rural Cambodia [9]. On the contrary, Changalucha et al (2002) reported that the prevalence of HIV from ANC underestimated community HIV prevalence in Tanzania [10]. Grassly, et al (2006) reviewed studies that have been carried out in different countries and compared estimates from ANC sentinel surveillance with population based estimates [11]. They found that in 12 out of 15 countries, HIV prevalence from ANC surveillance closely estimated the actual population prevalence. However, prevalence from ANC over-estimated community prevalence in Kenya and Rwanda, but underestimated the community prevalence in Zambia. Assuming that prevalence from ANC surveillance is representative of pregnant women, and that errors resulting from laboratory testing are minimal, one major explanation of inaccuracies in the estimates is the differences in the fertility rates between HIV positive and negative women. The accuracy of HIV estimates from ANC also depends on the contraceptive prevalence and ANC coverage.

Improved methods for estimating HIV prevalence such as population-based surveys can provide useful information on HIV prevalence levels and distribution, and improve HIV estimates at national and regional levels [12]. However, surveys may be costly especially when there are frequent and nation-wide.

Research on ANC sentinel surveillance has mainly been focused on the role of behavioural data in ANC surveillance [13], uses of prevalence data [14], coverage [15], assessing the trends of HIV prevalence [16-18], comparison between HIV prevalence from ANC and community prevalence [9,10] and methods of adjustment of estimates from ANC surveillance [11,19]. In addition some research has addressed the differences in fertility according to HIV status [2,20]. Glynn et al (2000) reported that the birth interval was reduced in HIV positive multiparous women compared to HIV-negative multiparous women in three African cities, namely Yaounde (Cameroon), Kisumu (Kenya) and Ndola (Zambia) [20].

Using sentinel data of pregnant women, the prevalence of HIV in Cameroon rose from 0.5% in 1987 to 10.8% in 2000 and then dropped to 7.3% in 2002 (Ministry of Public Health, 2001 and 2003) [21]. A population-based survey conducted in 2004 estimated the overall adult HIV prevalence in Cameroon to be 5.5% [22]. It is not clear whether this represents a true decrease in the prevalence of HIV or an artifact due to the differences in the two methods of data collection. Knowledge about the accuracy of sentinel prevalence as a proxy for national HIV prevalence is indispensable especially in a country facing rapid changes in the HIV prevalence. Differential prevalence of HIV in pregnant and non-pregnant women has been reported to be significantly associated with age, marital status, parity, schooling, and contraceptive use [23].

The purpose of our study was to compare the fertility rates of HIV-infected and HIV-uninfected women using population-based data in order to make recommendations on the appropriate adjustments when using sentinel data in designing and evaluating HIV prevention programmes in Cameroon.

Methods

Design

This study is a cross-sectional, population-based survey that uses data from the 2004 Cameroon Demographic and Health Survey (DHS) [22]. Women of reproductive age (15 to 49 years) were interviewed about their past and current reproductive history and tested for HIV after obtaining informed consent. Ethical approval was sought from the Cameroon Ministry of Health prior to the original survey [22].

Population and sampling

The survey used a two stage cluster sampling technique. The sample frame was a list of all Enumeration Areas (clusters) established by a General Census of Population and Housing in 2003. The first stage involved selecting 466 clusters (primary sampling units) with a probability proportional to the size, the size being the number of households in the cluster. The second stage involved the systematic sampling of households from the selected clusters. All women aged 15 to 49 years in the selected households were interviewed. The details of the study methods have been published elsewhere [22]. The current report included only sexually active women aged 15 to 49 years.

Laboratory analysis

The HIV status was screened by direct ELISA test (Genscreen Plus Version, BioRad Laboratories) and confirmed by a competitive ELISA test (Wellcozyme HIV-1 recombinant, ABBOTT, specific for HIV 1) and a rapid test (Determine, ABBOTT, specific for HIV 2). Only positive samples (with direct ELISA) were confirmed with competitive ELISA and only discordant samples were tested with Determine. All positive results in this survey were HIV-1: no HIV-2 was detected. For internal quality control, 5% of the HIV negative samples on direct ELISA were confirmed by competitive ELISA and Determine. Details of the testing algorithm has been published elsewhere [22].

Definitions

Fertility rates

We define the general fertility rate in this study as the total number of births in the 36 months preceding the survey divided by the total number of woman-years of exposure during that period (36 months) multiplied by 1000 [24]. The age-specific fertility rate is the value of fertility rate for seven five-year groups (15–19, 20–24, 25–29, 30–34, 35–39, 40–44 and 45–49 years). Woman-years of exposure is the sum of the number of months exposed in the five-year age bracket during the time period divided by 12.

Relative inclusion ratio

The relative inclusion ratio (RIR) is the ratio of the fertility rate in HIV positive women of reproductive age to the fertility rate of HIV negative women of reproductive age (15–49 years). Nicoll et al used this ratio to compare the relative fertility in HIV infected and uninfected women, so as to determine the relative likelihood of including these two groups of women in a seroprevalence survey in antenatal clinics [2]. A ratio of 1.00 suggests a good estimation; a ratio of less than 1.00 indicates an underestimation and a ratio of more than 1.00 is an over-estimation of the HIV prevalence in the general population. ANC-based HIV prevalence can be adjusted for the effect of differential fertility rates by using the formula "Adjusted HIV Prevalence = {Unadjusted HIV Prevalence}/{RIR}". For example if the Unadjusted ANC-HIV Prevalence is 7.5% and RIR is 0.75, then the Adjusted HIV Prevalence is 7.5/0.75 or 10.0%.

Wealth index

Wealth index was used as our measure of socio-economic status. A score was given to each available household amenity based on the Health, Nutrition and Population/Poverty Thematic Group of the World Bank [25]. The total score for each household constituted the wealth index score for that household. Each woman was assigned the wealth index score of her household. From this score we distinguished three equal-sized classes of participants according to their wealth, based on percentiles (<33.33 percentile, 33.33 to 66.66 percentile and >66.66 percentile).

Statistical Analyses

All cases in the DHS data are given weights to adjust for differences in probability of selection and to adjust for the non-response in order to produce the proper representation. Individual weights were used for secondary data analysis in this study. Data were analyzed using SPSS version 13.0 for Windows. The results are reported as rates or ratios with their corresponding 95% confidence intervals (CI) and a p-value less than 0.05 was considered significant.

Results

Characteristics of the study population

Overall, 4493 sexually active women participated in the survey, giving a response rate of 92.1%. Of this number, 336 (7.5%) were HIV positive. Table 1 presents the characteristics of the study population by HIV status. The mean age of women and the mean age at first intercourse were not significantly different between HIV positive and HIV negative women. The median parity was 2 (range 0 to 12) for HIV positive and 2 (range 0 to 14) for HIV negative women (p < 0.001). The prevalence of HIV infection was significantly higher in wealthier and more educated women (p < 0.001 for each). The prevalence also varied according to the marital status: 3.5% amongst women who have never married, 6.2% amongst currently married and 18.5% in divorced or widowed women (p < 0.001).

Table 1.

Distribution of socio-demographic characteristics of Cameroonian women of reproductive age by HIV status

Characteristic HIV positive N (%) HIV negative N (%) p-value
Mean age, years (SD) 29.3 (7.6) 28.9 (9.1) 0.304
Median age at first intercourse (range) 16(10–26) 16 (8–33) 0.167
Median parity (range) 2 (0–12) 2 (0–14) <0.001
Median number of living children (range) 2 (0–9) 2 (0–12) <0.001
Place of residence
Urban 228 (9.5) 2183 (90.5) <0.001
Rural 108 (5.2) 1973 (94.8)
Marital status
Never married 37 (6.5) 529 (93.5) <0.001
Currently married 218 (6.2) 3274 (93.8)
Formerly married 80 (18.5) 353 (81.5)
Education
No school 37 (3.5) 1035 (96.5) <0.001
Primary 143 (8.1) 1619 (91.9)
Secondary/higher 155 (9.4) 1502 (90.6)
Religion
Christians 276 (8.7) 2896 (91.3) <0.001
Muslims 45 (5.5) 778 (94.5)
Others 15 (3.0) 483 (97.0)
Wealth index
low 57 (3.8) 1441 (96.2) <0.001
middle 132 (8.8) 1368 (91.2)
high 146 (9.8) 1350 (90.2)
Open in a new tab

HIV = Human Immunodeficiency Virus

Fertility rates

Table 2 presents the age-specific fertility rates for rural areas. In the rural area, the fertility rate in both HIV positive and HIV negative women increased from 15–19 years to a maximum at 20–24 years and then decreased monotonically till the 35–49 years. However, in all age brackets the fertility rate was lower in the HIV positive compared to the HIV negative women. The overall fertility rate was 157.7 births per 1000 woman-years (95% CI 118.4 to 204.1) in HIV-infected women compared to 243.7 births per 1000 woman-years (95% CI 229.7 to 258.2) in uninfected women. Consequently, all relative inclusion ratios (RIRs) were lower than unity, and the overall RIR was 0.65 (95% CI 0.59 to 0.71).

Table 2.

Fertility rates and relative inclusion ratios (RIR) for HIV positive and HIV negative women by age in the rural area of Cameroon, 2004.

HIV positive women HIV negative women
Age
bracket
(years)		 Number of
births
(A1) 		Woman-years
at risk
(B1) 		Fertility rate
(95% CI)
C1 = (A1/B1)*1000 		Number of
births
(A2) 		Woman-years
at risk
(B2) 		Fertility rate
(95% CI)
C2 = (A2/B2)*1000 		RIR
(95% CI)
C1/C2
15–19 4 43.4 92.2 (30.3–209.3) 238 1518.8 156.7 (137.7–177.6) 0.59 (0.51–0.67)
20–24 14 72.0 194.4 (110.7–318.5) 347 1316.7 263.5 (236.9–292.4) 0.74 (0.68–0.79)
25–29 14 89.3 156.8 (89.2–256.8) 234 987.0 238.1 (209.0–237.7) 0.66 (0.60–0.72)
30–34 9 61.0 147.5 (72.0–270.8) 167 815.3 204.8 (175.5–237.7) 0.72 (0.66–0.78)
≥ 35 3 56.7 52.9 (13.5–144.0) 141 1506.4 94.3 (79.7–110.75) 0. 56 (0.46–0.67)
Total 44 279.0 157.7 (118.4–204.1) 1127 4625.4 243.7 (229.7–258.2) 0.65 (0.59–0.71)
Open in a new tab

CI = confidence interval; RIR = relative inclusion ratio; HIV = Human Immunodeficiency Virus

Table 3 compares the age-specific fertility rates of HIV positive and HIV negative women in urban areas. Similar trends are observed as in rural areas: fertility is higher in HIV negative than in HIV positive women in all but for the 15–19 year age brackets. However, the peak of fertility in urban areas is reached at a later age (25–29 years) than in rural areas (20–24 years). Like in rural areas, the overall fertility is lower in HIV positive (102.7 births per 1000 woman-years, 95% CI 80.7 to 129.0) than in HIV negative women (124.0 births per 1000 woman-years, 95% CI 116.0 to 1312.4) and consequently the relative inclusion ratio is low (0.83, 95% CI 0.76 to 0.89).

Table 3.

Fertility rates and relative inclusion ratios (RIR) for HIV positive and HIV negative women by age in the urban area of Cameroon, 2004.

HIV positive women HIV negative women
Age
bracket
(years)		 Number of
births
(A1) 		Woman-years
at risk
(B1) 		Fertility rate
(95% CI)
C1 = (A1/B1)*1000 		Number of
births
(A2) 		Woman-years
at risk
(B2) 		Fertility rate
(95% CI)
C2 = (A2/B2)*1000 		RIR
(95% CI)
C1/C2
15–19 14 84.4 165.8 (98.1–257.9) 196 2139.9 91.6 (79.4–105.1) 1.81 (1.59–2.08)
20–24 20 177.0 113.0 (71.0–171.4) 240 1491.0 161.0 (141.6–182.3) 0.70 (0.63–0.77)
25–29 25 185.3 134.9 (89.5–196.0) 219 1151.6 190.2 (166.2–216.6) 0.71 (0.64–0.77)
30–34 6 104.2 57.6 (23.3–119.8) 140 1050.4 133.3 (113.8–155.4) 0.44 (0.35–0.52)
≥ 35 5 130.6 38.3 (14.2–83.2) 83 1470.8 56.4 (45.3–69.7) 0.68 (0.55–0.79)
Total 70 681.5 102.7 (80.7–129.0) 878 7079.7 124.0 (116.0–1312.4) 0.83 (0.76–0.89)
Open in a new tab

CI = confidence interval; RIR = relative inclusion ratio; HIV = Human Immunodeficiency Virus

Overall, the fertility rate in all HIV positive women (rural and urban combined) was 118.7 births per 1000 woman-years (95% CI 98.4 to 142.0) compared to 171.3 births per 1000 woman-years (95% CI 164.5 to 178.2) for HIV negative women. Consequently, the summary RIR was 0.69 (95% CI 0.62 to 0.75). These values of fertility rates are self-weighted in terms of age and rural-urban differences because the sample represents all women of reproductive age in Cameroon.

Discussion

This study compared fertility rates in HIV-infected and uninfected women of reproductive age using population-based data. Our findings indicate that fertility rates are lower in HIV infected women compared to uninfected women in Cameroon.

Our finding of low fertility in HIV positive women is consistent with reports from other authors [3,4]. We found low fertility rates in HIV positive women of all age groups but for urban HIV-infected teenagers (that is, 15–19 year olds) who had a higher fertility rate than their corresponding HIV negative counterparts in cities. We could not find any suitable explanation to this finding. However, since the teenagers in rural areas were similar to other adult women in terms of their RIR, the cause is unlikely to be biological. We therefore attributed the high fertility in urban HIV-infected teenagers to differences in sexual and reproductive attitudes and practices. Monitoring of HIV epidemic via antenatal sentinel surveillance requires regular adjustments for many factors such as the differences in distribution of HIV across different age groups and different sub-populations, and differences in fertility rates between the infected and the uninfected women [26]. Adjustment for fertility rates is an important factor because modest changes in fertility can have profound effects on the validity of estimates from pregnant women [27]. Nicoll et al suggested that adjusting for the differences in fertility rates was sufficient in countries with overwhelming epidemics where the infection was transmitted through one source (heterosexual route) and many people are unaware of their HIV status [2]. The authors argued that it might be possible to use summary RIR in wider geographical area such as Sub-Saharan Africa. Our study reports the summary RIR for Cameroon. Since the study population was a representative sample of the all Cameroon women of reproductive age, our RIR is self-weighted for regional and age differences. Eighty three percent (83%) of Cameroonian women attend at least one antenatal visit during pregnancy [22]. However, the differences in utilization of antenatal services by HIV-positive and HIV-negative women could introduce bias in the ANC-based prevalence estimates.

Our study used fertility rates (number of births per 1000 woman years of exposure over 36 months) instead of live birth rates (number of live births per 100 woman years of exposure) as reported by Nicoll et al [2], because we consider that all pregnant women are equally likely to be tested for HIV infection irrespective of the birth outcome (dead or live births). Desgrées du Loû et al used parity as a proxy for fertility rate [28]. Parity is a cumulative measure of fertility and is insensitive to recent changes in fertility. In Zambia, ANC-based HIV estimates were found to substantially underestimate declines in HIV prevalence in the general population [29]. This was partly explained by changes in fertility-related behaviours among young women.

We found a summary RIR of 0.69 which is lower than that reported by other authors [4,28,30]. Nicoll et al reported a summary RIR of 1.03 for London and 0.80 for women else where in England and Wales [2]. The differences may be explained by socio-cultural differences of the two populations. Desgrées du Loû et al in Ivory Coast reported a summary RIR of 0.84 which is higher than our summary RIR [28]. This may be explained by the fact they used parity instead of fertility rates and collected data from antenatal clinics which may not accurately represent the whole population. Gray et al [4] is a population-based study in Uganda reported an unadjusted RIR of 0.78. Similarly, in another population-based study Terceira et al reported an unadjusted RIR of 0.78 in rural Zimbabwe [30]. The RIRs of these two studies are closer to that reported in our study and this could be explained by the fact that they all used population-based data for analysis.

The application of HIV seroprevalence from pregnant women to the whole female population needs adjustment for the differences in fertility rates among HIV-infected and HIV-uninfected women. Following earlier publications, fertility rate is now taken into consideration by the Joint United Nations Programme on HIV/AIDS (UNAIDS) when estimating and projecting HIV prevalences [31].

Conclusion

In conclusion, fertility rates are lower in HIV infected women compared to uninfected sexually active women in Cameroon. The findings of this study support the use of summary RIR for the adjustment of HIV prevalence (among adult female population) obtained from sentinel surveillance in antenatal clinics. Continuous monitoring of the fertility rates in HIV positive and HIV negative women should be an adjunct to HIV serosurveillance because fertility rates are not static, but change over time.

Conflict of interests

The authors declare that they have no competing interests.

Authors' contributions

EJ Kongnyuy conceived the study, and analyzed the data, and had primary responsibility for writing this paper. CS Wiysonge assisted in the critical revision of the manuscript for important intellectual content.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2458/8/309/prepub

Acknowledgments

Acknowledgements

The authors are grateful to Measure DHS for providing them with the 2004 Cameroon DHS data.

Contributor Information

Eugene J Kongnyuy, Email: kongnyuy@gmail.com.

Charles S Wiysonge, Email: wiysonge@yahoo.com.

References

  1. World Health Organisation . HIV/AIDS Epidemiological surveillance for the WHO African Region 2002. Harare Zimbabwe, WHO Regional Office for Africa; 2003. [Google Scholar]
  2. Nicoll A, Stephenson J, Griffioen A, Cliffe S, Rogers P, Boisson E. The relationship of HIV prevalence in pregnant women to that in women of reproductive age: a validated method for adjustment. AIDS. 1998;12:1861–1867. doi: 10.1097/00002030-199814000-00018. [DOI] [PubMed] [Google Scholar]
  3. Zaba B, Gregson S. Measuring the impact of HIV on fertility in Africa. AIDS. 1998;12:S41–S50. [PubMed] [Google Scholar]
  4. Gray R, Waver M, Serwadda D, et al. Population based study of fertility in women with HIV-1 infection in Uganda. Lancet. 1998;351:98–103. doi: 10.1016/S0140-6736(97)09381-1. [DOI] [PubMed] [Google Scholar]
  5. Dzekedzeke K, Fylkesnes KM. Reducing uncertainties in global HIV prevalence estimates: the case of Zambia. BMC Public Health. 2006;6:83. doi: 10.1186/1471-2458-6-83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Drey EA, Darney PD, Louie B, Kellogg TA, Kang MS, Prabhu R, Whitaker AK. HIV sentinel surveillance among women seeking elective pregnancy termination, San Francisco. Sex Transm Dis. 2005;32:590–592. doi: 10.1097/01.olq.0000175420.35851.6b. [DOI] [PubMed] [Google Scholar]
  7. Fylkesnes K, Ndhlovu Z, Kasumba K, Mubanga Musonda R, Sichone M. Studying dynamics of the HIV epidemic: population-based data compared with sentinel surveillance in Zambia. AIDS. 1998;12:1227–34. doi: 10.1097/00002030-199810000-00015. [DOI] [PubMed] [Google Scholar]
  8. Saphonn V, Parekh BS, Dobbs T, Mean C, Bun LH, Ly SP, Heng S, Detels R. Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999–2002. J Acquir Immune Defic Syndr. 2005;39:587–92. [PMC free article] [PubMed] [Google Scholar]
  9. Saphonn V, Hor LB, Ly SP, Chhuon S, Saidel T, Detels R. How well do antenatal clinic (ANC) attendees represent the general population? A comparison of HIV prevalence from ANC sentinel surveillance sites with a population-based survey of women aged 15–49 in Cambodia. Int J Epidemiol. 2002;31:449–455. doi: 10.1093/ije/31.2.449. [DOI] [PubMed] [Google Scholar]
  10. Changalucha J, Grosskurth H, Mwita W, Todd J, Ross D, Mayaud P, et al. Comparison of HIV prevalences in community-based and antenatal clinic surveys in rural Mwanza, Tanzania. AIDS. 2002;16:661–665. doi: 10.1097/00002030-200203080-00019. [DOI] [PubMed] [Google Scholar]
  11. Grassly NC, Morgan M, Walker N, Garnett G, Stanectki KA, Stover J, et al. Uncertainty in estimates of HIV?AIDS: the estimation and application of plausibility bounds. Sex Transm Inf. 2004;80:31–38. doi: 10.1136/sti.2004.010637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. García-Calleja JM, Gouws E, Ghys PD. National population based HIV prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS estimates. Sex Transm Infect. 2006;82:iii64–iii70. doi: 10.1136/sti.2006.019901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zaba B, Slaymaker E, Urassa M, Boerma JT. The role of behavioral data in HIV surveillance. AIDS. 2005;19:S39–52. doi: 10.1097/01.aids.0000172876.74886.86. [DOI] [PubMed] [Google Scholar]
  14. Fabiani M, Nattabi B, Ayella EO, Ogwang M, Declich S. Using prevalence data from the programme for the prevention of mother-to-child-transmission for HIV-1 surveillance in North Uganda. AIDS. 2005;19:823–827. doi: 10.1097/01.aids.0000168977.51843.d6. [DOI] [PubMed] [Google Scholar]
  15. Souza PR, Junior, Szwarcwald CL, Barbosa A, Junior, Carvalho MF, Castilho EA. HIV infection during pregnancy: the Sentinel Surveillance Project, Brazil, 2002. Rev Saude Publica. 2004;38:764–772. doi: 10.1590/s0034-89102004000600003. [DOI] [PubMed] [Google Scholar]
  16. Mahomva A, Greby S, Dube S, Mugurungi O, Hargrove J, Rosen D, et al. HIV prevalence and trends from data in Zimbabwe, 1997–2004. Sex Transm Infect. 2006;82:i42–7. doi: 10.1136/sti.2005.019174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Elharti E, Zidouh A, Mengad R, Bennani O, Elaouad R. Monitoring HIV through sentinel surveillance in Morocco. East Mediterr Health J. 2002;8:141–9. [PubMed] [Google Scholar]
  18. Kwesigabo G, Killewo J, Urassa W, Lugalla J, Emmelin M, Mutembei A, Mhalu F, Biberfeld G, Wall S, Sandstrom A. HIV-1 infection prevalence and incidence trends in areas of contrasting levels of infection in the Kagera region, Tanzania, 1987–2000. J Acquir Immune Defic Syndr. 2005;40:585–91. doi: 10.1097/01.qai.0000168183.22147.c4. [DOI] [PubMed] [Google Scholar]
  19. Fabiani M, Fylkesnes K, Nattabi B, Ayella EO, Declich S. Evaluating two adjustment methods to extrapolate HIV prevalence from pregnant women to the general female population in sub-Saharan Africa. AIDS. 2003;17:399–405. doi: 10.1097/00002030-200302140-00014. [DOI] [PubMed] [Google Scholar]
  20. Glynn JR, Buve A, Carael M, Kahindo M, Macauley IB, Musonda RM, Jungmann E, Tembo F, Zekeng L. Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. J Acquir Immune Defic Syndr. 2000;25:345–352. doi: 10.1097/00042560-200012010-00008. [DOI] [PubMed] [Google Scholar]
  21. Cameroon Ministry of Public Health . National HIV sentinel surveillance report 2003. Yaounde, Cameroon, Cameroon Ministry of Public Health/WHO; 2003. [Google Scholar]
  22. National Institute of Statistics, ORC Macro . Cameroon Demographic and Health Survey 2004. Calverton Maryland USA, NIS and ORC Macro; 2004. [Google Scholar]
  23. Glynn JR, Buve A, Carael M, Musonda RM, Kahindo M, Macauley I, et al. Factors influencing the difference in HIV prevalence between antenatal clinic and general population in sub-Saharan Africa. AIDS. 2001;15:1717–25. doi: 10.1097/00002030-200109070-00016. [DOI] [PubMed] [Google Scholar]
  24. Rutstein SD, Rojas G. Guide to DHS Statistics. Demographic and Health Surveys. Maryland USA, ORC Macro; 2003. [Google Scholar]
  25. Gwatkin DR, Rustein S, Johnson K, Pande R, Wagstaff A. Socio-economic differences in health, nutrition and population in Cameroon. New York, World Bank; 2000. [PubMed] [Google Scholar]
  26. Petruckevitch A, Nicoll A, Johnson AM, Bennett D. Direct estimates of prevalent HIV infection in adults in England and Wales from 1991 to 1993. Genitourin Med. 1997;73:348–354. doi: 10.1136/sti.73.5.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Boisson E, Nicoll A, Zaba B, Rodriques LC. Interpreting HIV seroprevalence data from pregnant women. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:434–439. doi: 10.1097/00042560-199612150-00006. [DOI] [PubMed] [Google Scholar]
  28. Desgrées du Loû A, Msellati P, La Ruche G, Welffens-Ekra C, Ramon R, Dabis F. Estimation of HIV-1 prevalence in the population of Abidjan by adjustment of the prevalence observed in antenatal centres. AIDS. 1999;13:1598–1599. doi: 10.1097/00002030-199908200-00032. [DOI] [PubMed] [Google Scholar]
  29. Michelo C, Sandøy I, Fylkesnes K. Antenatal clinic HIV data found to underestimate actual prevalence declines: evidence from Zambia. Trop Med Int Health. 2008;13:171–179. doi: 10.1111/j.1365-3156.2007.01987.x. [DOI] [PubMed] [Google Scholar]
  30. Terceira N, Gregson S, Zaba B, Mason PR. The contribution of HIV to fertility decline in rural Zimbabwe, 1985–2000. Population Studies. 2003;57:149–164. doi: 10.1080/0032472032000097074. [DOI] [PubMed] [Google Scholar]
  31. Stover J, Walker N, Grassly NC, Marston M. Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sexually Transmitted Infections. 2006;82:iii45–iii50. doi: 10.1136/sti.2006.020172. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Public Health are provided here courtesy of BMC

RESOURCES